Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Oxcarbazepine I.P. 300mg Tablet
Therapeutic Category
Neurology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹229/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Oxcarbazepine I.P. 300mg tablet is an anti-epileptic formulation used for the effective management of partial seizures and epilepsy disorders.
It works by stabilizing hyperexcited neuronal membranes and inhibiting repetitive firing of nerve impulses, thereby helping reduce seizure frequency and intensity.
This tablet is commonly prescribed for partial-onset seizures in adults and children, either as monotherapy or adjunctive therapy, ensuring improved neurological stability and patient quality of life.
With proven anticonvulsant efficacy, reliable bioavailability, and strong demand in neurology practice, this formulation strengthens a neuro-therapy portfolio and supports consistent growth in seizure management treatment.
Common side effects may include dizziness, drowsiness, headache, nausea, vomiting, blurred vision, or fatigue. Rarely, hyponatremia or serious skin reactions may occur and require medical attention.
Oxcelzine 300 Tablet is indicated for the treatment of partial seizures in adults and children, either as monotherapy or adjunctive therapy, as prescribed by a healthcare professional.
For oral use only. Use strictly under medical supervision. Do not discontinue abruptly, as it may increase seizure frequency. Periodic monitoring of sodium levels may be required during prolonged therapy.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.
Composition : Neurological Disorder Syrup
Composition : Divalproex (250mg) Prolonged Release
Composition : Gabapentin (400mg) + Nortriptyline Hydrochloride (10mg)
Composition : Sodium Valproate I.P. 133mg + Valproic Acid I.P. 58mg (C.R.)
Composition : Sodium Valproate 200mg + Valproic Acid 87mg
Composition : Sodium Valproate (333mg) + Valproic Acid (145mg) Tablet
Composition : Brivaracetam I.P. 100mg Tablet
Composition : Brivaracetam I.P. 50mg Tablet
Composition : Divalproex (500mg) Prolonged Release Tablet
Composition : Duloxetine (20mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Oxcarbazepine 300 mg Tablet presents strong business opportunities in the neurology and anticonvulsant therapy segment, making it a valuable product for PCD pharma franchise partners, distributors, and wholesalers. Due to the increasing diagnosis of epilepsy and other neurological disorders requiring long-term treatment, Oxcarbazepine 300 mg Tablet maintains consistent prescription demand from neurologists, hospitals, specialty clinics, and healthcare institutions.
Medical distributors and franchise partners can benefit from the stable demand generated by neurological therapies. Widely prescribed for the management of epilepsy and seizure disorders under medical supervision Commonly recommended by neurologists and healthcare professionals Long-term treatment requirements contribute to repeat prescription demand Strong utilization in hospitals, neurology clinics, and specialty healthcare centers Growing focus on neurological healthcare supports sustained market demand This strengthens a comprehensive neurology and chronic care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Oxcarbazepine 300 mg Tablet with exclusive monopoly rights, promotional support, attractive packaging, and competitive pricing for distributors, stockists, and wholesalers across India.
Wholesalers and medical agencies benefit from: Consistent prescription-driven demand in the neurology segment Strong repeat sales due to chronic therapy usage Reliable supply chain support and timely product availability Growing market demand for neurological care products Attractive margins and long-term business growth opportunities These benefits help ensure sustainable sales and business expansion.
Interested distributors, stockists, and pharma entrepreneurs can partner with Cafoli LifeCare Pvt Ltd to access profitable PCD pharma franchise opportunities for Oxcarbazepine 300 mg Tablet. With exclusive monopoly rights, extensive promotional support, quality-focused manufacturing standards, attractive profit margins, and dependable logistics services, Cafoli LifeCare Pvt Ltd helps franchise partners build and expand a successful pharmaceutical business across India.